Lv6
1718 积分 2021-12-24 加入
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
2天前
已完结
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
15天前
已完结
The evolving landscape of obesity pharmacotherapy
15天前
已完结
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR
15天前
已完结
Discovery of Dual A2A/A2B Adenosine Receptor Antagonist and Clinical Candidate INCB106385
16天前
已完结
Solubility-Driven Lead Optimization of PAR4 Antagonists and Evaluation of a Phosphate Ester Prodrug Delivery Strategy
1个月前
已完结
Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer
1个月前
已完结
Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon
1个月前
已完结
Discovery and Characterization of Zilurgisertib, a Potent and Selective Inhibitor of Activin Receptor-like Kinase-2 (ALK2) for the Treatment of Fibrodysplasia Ossificans Progressiva
1个月前
已完结
The Development of UM-203, A Reversible Covalent STING Antagonist
1个月前
已完结
皖公网安备34019202002308
